Editorial

A brief overview of Obama's healthcare plan and its potential economic implications, as well as criticisms from health economists.

Dr. Walter Tsou discusses the potential benefits of a universal, government-run health system in the United States, including efficiency and equity

Pharmaceutical company Eli Lilly announces plans to disclose payments made to physicians.

Learn about the possible change in attitude toward the role of pharma in providing healthcare information in Europe.

A look into the controversial concept of disease-mongering and its potential consequences

An overview of the NHS's transformation and its plans for the future, focusing on personalisation and individualisation of care

The conflict between top-down evaluation and personalised medicine in healthcare systems

A look at direct-to-consumer advertising in the pharmaceutical industry, its regulations, and the impact on patients

Exploring the Growing Trend of Big-Box Companies Involvement in Healthcare Delivery

Dr. Vagelos discusses pricing, global good works, credibility, and the future of the pharmaceutical industry

Tips for health economists to research new career directions, enhance skills and build professional networks during industry downturns.

A balanced look at the impact of DTC advertising in healthcare

The article discusses the shift from chemical-based pharma products to protein-based biotech products, and its impact on health economics

This article discusses the potential of technology, such as Microsoft and Google's initiatives, to improve the fragmented healthcare system by creating a more patient-centric approach, fostering collaboration and reducing inefficiencies.

Clinical trials outsourcing trends and cost advantages